BITAMMON

Medicinal product

(Invented) name

BITAMMON

Active substance (s)

Sultamicilinas

Strength

250 mg/5 ml

Pharmaceutical form

milteliai geriamajai suspensijai

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

J01CR04, Sultamicillin

Marketing authorisation holder

UAB Niromed, Lietuva

Date of authorisation

2023-11-22

Date of renewal

Documents

2032_BITAMMON 250 mg_5 ml milteliai geriamajai suspensijai_PZPL_2023-11-22.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

5 ml suspensijos yra	5 ml
Sultamicilinas	250 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
112160	98275	1098275	buteliukas	70 ml, N1		Receptinis	LT/L/23/2032/001	Netiekiama	2024-12-16	2025-06-30	Yes	2025-01-01	2025-06-30	Download

Stadijos

Data	Stadija
2023-11-22	Registruotas